Published in Australas Ann Med on November 01, 1967
The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol (1974) 1.51
Adrenal cortical function in children on steroids. Arch Dis Child (1970) 1.07
Plasma cortisol and the use of hydrocortisone in the treatment of status asthmaticus. Thorax (1973) 0.99
The effect of prednisone treatment on the half-life of intravenous hydrocortisone. Br J Clin Pharmacol (1974) 0.89
Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax (1992) 0.86
Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology (1992) 0.85
Tetracosactrin for the management of asthmatic patients after long-term corticosteroids. Thorax (1975) 0.79
Barbiturates in asthma. Br Med J (1972) 0.75
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41
Exposure measurement error: influence on exposure-disease. Relationships and methods of correction. Annu Rev Public Health (1993) 4.15
Standardisation of human chorionic gonadotropin, hCG subunits, and pregnancy tests. Lancet (1982) 3.60
Depressed lymphocyte function after bereavement. Lancet (1977) 3.45
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med (1990) 3.42
Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73
A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics (1994) 2.35
The gastrointestinal stimulus to insulin release. I. Secretin. J Clin Invest (1969) 2.24
The medical problems of mass participation in athletic competition. The "City-to-Surf" race. Med J Aust (1972) 2.21
What is myalgic encephalomyelitis? Lancet (1988) 2.17
Health outcomes: of means and ends. Med J Aust (1995) 2.02
Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. Ann Intern Med (1990) 1.93
Androgen responses during physical exercise. Br Med J (1973) 1.87
Pulmonary tuberous sclerosis. Report of three patients and a review of the literature. Q J Med (1971) 1.85
Carrier solutions for low-level intravenous insulin infusion. Br Med J (1975) 1.83
Prolactin secretion by metoclopramide in man. J Clin Endocrinol Metab (1976) 1.78
Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med (1998) 1.76
Treatment of severe diabetes mellitus by insulin infusion. Br Med J (1974) 1.61
Effect of severe, chronic illness on thyroid function. Lancet (1974) 1.61
Binge eating disorder in extreme obesity. Int J Obes Relat Metab Disord (2002) 1.53
Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J Appl Physiol (1976) 1.51
The correlation between skin tests, bronchial provocation tests and the serum level of IgE specific for common allergens in patients with asthma. Clin Allergy (1975) 1.45
Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin. J Am Coll Cardiol (1990) 1.44
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial. Clin Oncol (R Coll Radiol) (2008) 1.42
Control of heart-rate in healthy young men. Lancet (1967) 1.40
The potential organ donor. Med J Aust (1993) 1.40
Nutrition and quality of life in older adults. J Gerontol A Biol Sci Med Sci (2001) 1.39
Growth hormone release during sleep in growth retarded children. Arch Dis Child (1973) 1.39
What will be the outcome of the outcomes movement? Aust N Z J Med (1995) 1.39
High density lipoproteins, genetic polymorphism for apo A-I and coronary artery disease. Aust N Z J Med (1991) 1.39
The boundaryless hospital. Aust N Z J Med (1994) 1.37
Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet (1986) 1.34
Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg (1986) 1.34
Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst (1980) 1.32
Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab (1991) 1.29
Serum gastrin in patients with peptic ulceration. Br Med J (1970) 1.25
Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. N Engl J Med (1988) 1.21
Client flow analysis: a practical management technique for outpatient clinic settings. Int J Qual Health Care (1994) 1.20
Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol (1990) 1.19
Flavonoid intake and breast cancer risk: a case--control study in Greece. Br J Cancer (2003) 1.19
Radioimmunoassay of pancreozymin cholecystokinin in human serum. J Nucl Med (1969) 1.17
New type of allergic asthma due to IgG "reaginic" antibody. Br Med J (1973) 1.15
Acute severe cardiac failure complicating myocardial infarction. Experience with 100 patients referred for consideration of mechanical left ventricular assistance. Br Heart J (1975) 1.15
The effect of puberty on growth hormone secretion in boys with short stature and delayed adolescence. Aust N Z J Med (1971) 1.14
Hospitals: to the next millennium. Int J Health Plann Manage (1995) 1.14
American Cancer Society guidelines on diet, nutrition, and cancer. The Work Study Group on Diet, Nutrition, and Cancer. CA Cancer J Clin (1991) 1.13
The gastrointestinal stimulus to insulin release. II. A dual action of secretin. J Clin Invest (1970) 1.13
Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem (1992) 1.10
Regulation of acetylcholine receptor phosphorylation by calcium and calmodulin. Proc Natl Acad Sci U S A (1981) 1.09
Caveat emptor: assessing needs, evaluating computer options. J Am Diet Assoc (1984) 1.08
Position statement on the use of antiretroviral therapy to reduce HIV transmission, January 2013: the British HIV Association (BHIVA) and the Expert Advisory Group on AIDS (EAGA). HIV Med (2013) 1.07
Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol (1996) 1.07
Reducing the great American waistline. Am J Public Health (1986) 1.07
Radioimmunoassay of secretin in human serum. J Nucl Med (1968) 1.06
Circulating thyroid hormone levels in children. Arch Dis Child (1977) 1.05
Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control (2004) 1.05
The School Nutrition Dietary Assessment Study. Am J Clin Nutr (1995) 1.04
Identification of IgG antibody as a carrier of reaginic activity in asthmatic patients. J Allergy Clin Immunol (1975) 1.02
Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Med J Aust (1970) 1.02
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01
Resting metabolic rate and body composition of Pima Indian and Caucasian children. Int J Obes Relat Metab Disord (1992) 1.01
Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. J Biol Chem (1987) 1.01
The hormonal response to physical exercise. Australas Ann Med (1969) 1.00
Serum-growth-hormone in acromegaly. Effect of cryogenic pituitary destruction. Lancet (1966) 0.99
Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study. J Pathol (2003) 0.99
Central core disease: clinical, pathological, and genetic features. Arch Dis Child (2003) 0.98
Inhibition of conversion of thyroxine to triiodothyronine in patients with severe chronic illness. Clin Endocrinol (Oxf) (1976) 0.98
Microbiological quality control of sterilized products: evaluation of a model relating frequency of contaminated items with increasing radiation treatment. J Appl Bacteriol (1971) 0.97
Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: are there new roles for preventative factors? Nutr Rev (1994) 0.97
Integration of the Continuing Survey of Food Intakes by Individuals and the National Health And Nutrition Examination Survey. J Am Diet Assoc (2001) 0.95
The effect of a low fat diet on estrogen metabolism. J Clin Endocrinol Metab (1987) 0.94
Control of blood glucose in diabetics using an artificial pancreas. Aust N Z J Med (1977) 0.94
Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy. Br Med J (1977) 0.93
Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab (1983) 0.92
Fixation protocols for subcellular imaging by synchrotron-based Fourier transform infrared microspectroscopy. Biopolymers (2005) 0.92
The many faces of gastrin. Australas Ann Med (1970) 0.92
PEIRS: a pathologist-maintained expert system for the interpretation of chemical pathology reports. Pathology (1993) 0.92
Impact of fat reduction on micronutrient density of children's diets: the CATCH Study. Prev Med (1996) 0.92
Timing of cardiac transplantation in idiopathic dilated cardiomyopathy. Am J Cardiol (1988) 0.92
On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis (1985) 0.91
Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes. Clin Exp Immunol (1999) 0.91
Blood glucose and serum insulin in reversible and irreversible posthemorrhagic shock. J Trauma (1966) 0.91
Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis (1991) 0.91
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res (1986) 0.90
Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med (1997) 0.90
Growth hormone regulation by melatonin and serotonin. Nature (1973) 0.90
Intake of specific flavonoid classes and coronary heart disease--a case-control study in Greece. Eur J Clin Nutr (2004) 0.90
Secretin and pancreozymin-cholecystokinin after glucose. Lancet (1968) 0.89
Changing concepts in management of infective endocarditis. Med J Aust (1977) 0.89
Cooperative relationships between professional societies and the food industry: opportunities or problems? Nutr Rev (1992) 0.88
Radioimmunoassay of human growth hormone using ion exchange resin. J Clin Endocrinol Metab (1966) 0.88
Hormonal responses to insulin infusion in diabetes mellitus. Diabetologia (1979) 0.88
The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies. Ann N Y Acad Sci (1977) 0.88
Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rat. J Lipid Res (1985) 0.88
The mouse fibroblast growth hormone receptor: ligand processing and receptor modulation and turnover. Endocrinology (1984) 0.87
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res (1984) 0.87
Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol (1987) 0.87
Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion. Metabolism (1983) 0.87